Allocation concealment is the protection of an upcoming treatment assignment from disclosure before a participant has been enrolled and assigned to a study group. In a randomized controlled trial, it prevents people involved in recruitment from knowing which intervention the next eligible participant will receive. Its purpose is to preserve the integrity of randomization by preventing foreknowledge from influencing who enters the trial or when they enter.
Purpose and principle
Random allocation creates treatment groups through a chance-based process rather than through decisions by participants or investigators. However, generating a genuinely random sequence is not sufficient to protect a trial against bias. If recruiters can inspect or predict upcoming assignments, they may consciously or unconsciously influence which participants receive particular interventions.
For example, a recruiter who knows that the next assignment is to an experimental treatment might delay enrolling a participant with a poor prognosis, or preferentially enrol someone expected to benefit. The resulting groups may differ in their underlying likelihood of a favourable outcome, independently of any treatment effect. This is a form of selection bias.
Allocation concealment addresses this vulnerability at the point of entry into the trial. The central requirement is that the decision to enrol a particular participant cannot be changed in response to knowledge of that participant’s upcoming assignment.
Relationship to randomization and blinding
Three procedures have distinct functions:
| Procedure | Main function | Relevant stage |
|---|---|---|
| Random sequence generation | Creates assignments through a chance-based process | Before or during allocation |
| Allocation concealment | Prevents foreknowledge of upcoming assignments from influencing enrolment | Before and up to assignment |
| Blinding | Prevents knowledge of assigned interventions from influencing subsequent conduct or assessment | After assignment |
A computer-generated random list can still be inadequately concealed if recruiters can access it. Conversely, a securely hidden schedule based on alternation does not constitute proper randomization: once previous assignments are known, later assignments can be predicted.
Blinding concerns knowledge of an assignment after it has occurred. It may involve participants, treating clinicians, outcome assessors, or analysts. Allocation concealment instead concerns access to the assignment before it is made.
The distinction matters in trials where blinding is impractical. In a comparison of surgery with nonsurgical treatment, for example, clinicians and participants will generally know which intervention was received. Nevertheless, upcoming assignments can remain concealed during recruitment. Similarly, describing a trial as “double-blind” does not establish that its allocation process was adequately concealed.
Methods
Centralized allocation
A centralized service can release an assignment only after the recruiting site has registered the participant and confirmed the required enrolment information. Telephone and web-based randomization systems are common examples.
The protection depends on implementation. Restricted access to the sequence, controls against repeated allocation requests, and records of assignment activity help prevent recruiters from inspecting future allocations or obtaining several assignments and selecting among them.
Pharmacy-controlled allocation and coded containers
An independent pharmacy or coordinating centre may hold the allocation schedule and supply consecutively numbered treatment packs. Recruiting staff issue the next pack without knowing which intervention it contains.
This approach can also support blinding when active treatment and placebo preparations are indistinguishable. Nevertheless, concealing future assignments and masking the contents of an issued pack remain separate methodological functions.
Sequentially numbered, opaque, sealed envelopes
Envelopes can conceal assignments when they are prepared and administered securely. Relevant features include sequential numbering, genuinely opaque materials, secure seals, and opening only after the participant’s identity and enrolment have been recorded.
Envelope systems are vulnerable to predictable failures: envelopes may be opened early, held against a light, replaced, or taken out of order. A report stating only that “sealed envelopes” were used provides insufficient detail to establish adequate concealment.
Predictability and failures of concealment
Concealment can fail without direct access to the allocation list. Recruiters may infer the next assignment from the allocation rule or from previous assignments.
With fixed blocks of a known size, for example, the final assignment in a block may become predictable if earlier assignments are visible. Randomly varying block sizes can reduce this predictability, but does not replace protection of the sequence itself.
Alternation, date of birth, admission date, and medical record numbers are predictable assignment rules rather than genuinely random methods. Such procedures do not provide the same protection against selective enrolment.
Other failures include unrestricted access to allocation files, revealing treatment codes in advance, and allowing staff to cancel an unwanted assignment and request another. A technically secure randomization system may therefore be undermined by the surrounding recruitment process.
Reporting and assessment
The CONSORT statement distinguishes sequence generation, the allocation-concealment mechanism, and the roles of people implementing randomization. Informative reporting describes how assignments were protected and who generated the sequence, enrolled participants, and assigned interventions.
Terms such as “randomized,” “centrally allocated,” or “sealed envelopes” are not equally informative without operational details. An assessment of concealment considers whether anyone capable of influencing enrolment could have known or predicted upcoming assignments.
In systematic reviews and other assessments of trial validity, inadequate concealment raises concern about bias arising from the randomization process. Insufficient reporting creates uncertainty, but does not by itself prove that concealment failed.
Baseline characteristics can provide additional context, although they are not a definitive test. Chance imbalances occur in properly randomized trials, especially small ones. Conversely, apparently balanced groups do not establish that assignments were concealed.
Scope and limitations
Allocation concealment protects against a particular source of bias; it does not guarantee that a trial is otherwise valid. It does not prevent biased outcome assessment, unequal care after allocation, missing outcome data, or selective reporting. Nor does it ensure that the enrolled population represents everyone who might receive the intervention.
The timing of recruitment is especially important in a cluster randomized trial. If hospitals, practices, or other clusters are assigned before individual participants are recruited, recruiters may already know the cluster’s intervention. Concealing the original cluster allocation does not eliminate the possibility of differential recruitment afterward. This is a distinct vulnerability of designs in which participant identification occurs after group assignment.
Finally, intention-to-treat analysis preserves comparisons according to assigned groups, but does not undo selection bias introduced through foreknowledge during enrolment. Secure allocation and appropriate analysis address different stages of trial validity.